Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response

Am J Transplant. 2022 Nov;22(11):2704-2706. doi: 10.1111/ajt.17091. Epub 2022 May 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • Antibody Formation
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Kidney Transplantation*
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • COVID-19 Vaccines
  • Antibodies, Viral